TRVI Stock Analysis: Buy, Sell, or Hold?
TRVI - Trevi Therapeutics, Inc. Common Stock
$11.44
-0.04 (-0.39%)
▼
5d:
+8.8%
30d:
+0.66%
90d:
+6.87%
BUY
HIGH Confidence
Last Updated: February 3, 2026
Earnings: Mar 17, 2026
Get Alerted When TRVI Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: TRVI shows strong fundamentals and good volume confirmation. Solid entry point despite fair pricing.
✅ BUY SIGNAL: TRVI shows strong fundamentals and good volume confirmation. Solid entry point despite fair pricing.
In-depth Analysis How we analyze
Valuation Analysis: TRVI is currently trading at $11.44, which is considered fair relative to its 30-day fair value range of $10.41 to $11.99.
Technical Outlook: Technically, TRVI is in a uptrend. The price is approaching resistance at $11.65. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: TRVI has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $21.80 (+89.9%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, TRVI is in a uptrend. The price is approaching resistance at $11.65. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: TRVI has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $21.80 (+89.9%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
FAIR
Fair Price Range
$10.41 -
$11.99
Company Quality Score
56/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
86.8%
All Signals
- NEUTRAL: Price in fair range
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 89.9% below Wall St target ($21.80)
Fair Price Analysis
30-Day Fair Range
$10.41 -
$11.99
Current vs Fair Value
FAIR
Support & Resistance Levels
Support Level
$9.85
Resistance Level
$11.65
Current Trend
Uptrend
Fundamental Context
Forward P/E (Next Year Est.)
-24.43
Wall Street Target
$21.80
(+89.9%)
Last updated: February 04, 2026 10:45 AM ET
Data refreshes hourly during market hours. Next update: 11:45 AM
Data refreshes hourly during market hours. Next update: 11:45 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is TRVI showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ONC
BeiGene, Ltd. |
STRONG BUY
24 analysts |
$404 | 61 BUY |
|
RARE
Ultragenyx |
STRONG BUY
20 analysts |
$64 | 63 BUY |
|
INSM
Insmed Inc |
STRONG BUY
19 analysts |
$215 | 58 HOLD |
|
RCKT
Rocket Pharmaceuticals I… |
STRONG BUY
18 analysts |
$8 | 54 HOLD |
|
CRNX
Crinetics Pharmaceutical… |
STRONG BUY
17 analysts |
$84 | 56 HOLD |
Advanced TRVI Option Strategies
Professional options setups generated by AI based on today's TRVI price and gamma walls.
